Literature DB >> 20950956

Four-dimensional positron emission tomography: implications for dose painting of high-uptake regions.

Michalis Aristophanous1, Jeffrey T Yap, Joseph H Killoran, Aileen B Chen, Ross I Berbeco.   

Abstract

PURPOSE: To investigate the behavior of tumor subvolumes of high [18F]-fluorodeoxyglucose (FDG) uptake as seen on clinical four-dimensional (4D) FDG-positron emission tomography (PET) scans. METHODS AND MATERIALS: Four-dimensional FDG-PET/computed tomography scans from 13 patients taken before radiotherapy were available. The analysis was focused on regions of high uptake that are potential dose-painting targets. A total of 17 lesions (primary tumors and lymph nodes) were analyzed. On each one of the five phases of the 4D scan a classification algorithm was applied to obtain the region of highest uptake and segment the tumor volume. We looked at the behavior of both the high-uptake subvolume, called "Boost," and the segmented tumor volume, called "Target." We measured several quantities that characterize the Target and Boost volumes and quantified correlations between them.
RESULTS: The behavior of the Target could not always predict the behavior of the Boost. The shape deformation of the Boost regions was on average 133% higher than that of the Target. The gross to internal target volume expansion was on average 27.4% for the Target and 64% for the Boost, a statistically significant difference (p < 0.05). Finally, the inhale-to-exhale phase (20%) had the highest shape deformation for the Boost regions.
CONCLUSIONS: A complex relationship between the measured quantities for the Boost and Target volumes is revealed. The results suggest that in cases in which advanced therapy techniques such as dose painting are being used, a close examination of the 4D PET scan should be performed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20950956     DOI: 10.1016/j.ijrobp.2010.08.028

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Assessment of patient selection criteria for quantitative imaging with respiratory-gated positron emission tomography.

Authors:  Stephen R Bowen; Larry A Pierce; Adam M Alessio; Chi Liu; Scott D Wollenweber; Charles W Stearns; Paul E Kinahan
Journal:  J Med Imaging (Bellingham)       Date:  2014-09-24

2.  Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.

Authors:  Mathieu Hatt; John A Lee; Charles R Schmidtlein; Issam El Naqa; Curtis Caldwell; Elisabetta De Bernardi; Wei Lu; Shiva Das; Xavier Geets; Vincent Gregoire; Robert Jeraj; Michael P MacManus; Osama R Mawlawi; Ursula Nestle; Andrei B Pugachev; Heiko Schöder; Tony Shepherd; Emiliano Spezi; Dimitris Visvikis; Habib Zaidi; Assen S Kirov
Journal:  Med Phys       Date:  2017-05-18       Impact factor: 4.071

3.  Respiratory trace feature analysis for the prediction of respiratory-gated PET quantification.

Authors:  Shouyi Wang; Stephen R Bowen; W Art Chaovalitwongse; George A Sandison; Thomas J Grabowski; Paul E Kinahan
Journal:  Phys Med Biol       Date:  2014-02-07       Impact factor: 3.609

4.  A comparison of amplitude-based and phase-based positron emission tomography gating algorithms for segmentation of internal target volumes of tumors subject to respiratory motion.

Authors:  Shyam S Jani; Clifford G Robinson; Magnus Dahlbom; Benjamin M White; David H Thomas; Sergio Gaudio; Daniel A Low; James M Lamb
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-11-01       Impact factor: 7.038

Review 5.  Advances in 4D radiation therapy for managing respiration: part I - 4D imaging.

Authors:  Geoffrey D Hugo; Mihaela Rosu
Journal:  Z Med Phys       Date:  2012-07-10       Impact factor: 4.820

6.  Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study.

Authors:  S R Bowen; M J Nyflot; C Herrmann; C M Groh; J Meyer; S D Wollenweber; C W Stearns; P E Kinahan; G A Sandison
Journal:  Phys Med Biol       Date:  2015-04-17       Impact factor: 3.609

7.  Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineation.

Authors:  Mathieu Hatt; Catherine Cheze-le Rest; Angela van Baardwijk; Philippe Lambin; Olivier Pradier; Dimitris Visvikis
Journal:  J Nucl Med       Date:  2011-10-11       Impact factor: 10.057

8.  Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy.

Authors:  Eunsin Lee; Jing Zeng; Robert S Miyaoka; Jatinder Saini; Paul E Kinahan; George A Sandison; Tony Wong; Hubert J Vesselle; Ramesh Rengan; Stephen R Bowen
Journal:  Med Phys       Date:  2017-06-01       Impact factor: 4.071

9.  Impact of tumour motion compensation and delineation methods on FDG PET-based dose painting plan quality for NSCLC radiation therapy.

Authors:  Hannah Mary Thomas; Paul E Kinahan; James Jebaseelan E Samuel; Stephen R Bowen
Journal:  J Med Imaging Radiat Oncol       Date:  2017-11-28       Impact factor: 1.735

10.  Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective.

Authors:  Stephen R Bowen; Matthew J Nyflot; Michael Gensheimer; Kristi R G Hendrickson; Paul E Kinahan; George A Sandison; Shilpen A Patel
Journal:  Clin Transl Med       Date:  2012-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.